AnnouncementJuly 12
Company Operations During COVID-19 Imposed State of Emergency
Our sincere condolences to victims of COVID-19, and hopes for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront of the fight against the virus, and everyone helping to support the community infrastructure.
Responding to the COVID-19 state of emergency for Tokyo declared by the Japanese government on July 12, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be closing the following company sites from July 13, prioritizing the safety of customers and employees. During the closure, PHC Group employees at the sites listed below will continue business operations by working from home, except in special cases where they perform essential duties that cannot be performed remotely, and will respond to customer inquiries by e-mail, phone calls, etc.
● Site closures
| PHC Holdings Corporation |
Shimbashi Headquarters
Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo |
| PHC Corporation |
Shimbashi Headquarters
Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
Biomedical Business Unit
・Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office
Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
・South Kanto Sales Office
Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa
Medical Information Systems Business Unit
・Business Transformation Center
Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo
・Omiya Office
Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama
Epredia Anatomical Pathology Business Unit
・Shinkoyasu Manufacturing Site
Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa
・CS Repair Warehouse
Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo
Shonan Health Innovation Park Office
Address: Shonan Health Innovation Park BW3M-2320, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa |
Details of additional upcoming measures at the above sites will be announced respectively by each business division in charge, where appropriate. Resuming of operations at the sites will be considered depending on national and local government policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience.
Other PHC Corporation sites in Japan will continue operations as usual at their offices, plants, etc. Details for other PHC Group companies will be announced separately and we ask you to refer to each company's website for further information.
The health and safety of our customers, patients, employees and their families are most important to the PHC Group and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.